MEDTRONIC, Abbott, and Boston Scientific Corporation Dominated the Global Active Medical Implantable Devices Market in 2021

Global Active Medical Implantable Devices Market is expected to grow with the CAGR of 8.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below.

Access Full Report @ https://www.databridgemarketresearch.com/reports/global-active-medical-implantable-devices-market

Global active medical implantable devices market is a highly consolidated market, which includes specific number of key players. The market has witnessed increased strategic developments owing to favorable market scenario.

Major players dealing in the global active medical implantable devices market are introducing a wide range of products adopting strategic initiatives, such as acquisitions, agreements, business expansions, awards and recognitions, into the market. This helps the companies to maximize the sales with enhanced product portfolio.

For instance:

  • In January 2021, Boston Scientific announced that it has received FDA approval for Vercise Deep Brain Stimulation System. The portfolio consists of implantable pulse generator designed to provide optimal symptom relief. This will help the company to expand its business in coming years
  • In July 2020, Medtronic announced that it has entered into a non-exclusive patent cross-license agreement for certain technologies in the field of diabetes. This will help the company to focus on helping people with diabetes through innovative products.
  • In December 2020, Abbott received approval by Health Canada for its product FreeStyle Libre 2 for adults and children with diabetes which measure glucose data every minute with customizable and optional real time alarms. This will help the company to diversify its market and grow in coming years.

Medtronic Company is the dominating player in the global active medical implantable devices market. Other key players existing in the market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics among others.

Active Medical Implantable Devices MarketMedtronic

Medtronic was founded in the year 1949 and is headquartered in Dublin, Ireland. The company is engaged in the development, manufacturing, distribution, and sale of medical devices and services. The company operates its business via several business segments including cardiovascular, medical surgical, neuroscience, and diabetes in which cardiovascular, neuroscience, diabetes are the market focused segments.

The company provides products via various product categories including advanced surgical technologies, cardiac rhythm, cardiovascular, diabetes, digestive & gastrointestinal, ear, nose & throat, general surgery, gynecology, neurology, oral & maxillofacial, patient monitoring, renal care, respiratory, spinal & orthopaedic, surgical navigation & imaging, urological, product manual, product performance, and advisories in which cardiac rhythm, diabetes, ear, nose & throat, are urological are market focused categories.

For instance,

  • In August 2020, Medtronic announced the acquisition of Companion Medical, a private company manufacturer of InPen. This will expand the company’s ability to better serve people with diabetes

The company has wide presence across Middle East and Africa, Americas, Europe, Asia-Pacific. The company also has various subsidiary companies including Medtronic of Canada Ltd. (Canada), Mazor Robotics (Israel), HeartWare International Inc. (U.S.), Titan Spine, Inc. (U.S.), and Given Imaging (Israel) among others.

Abbott

Abbott was founded in the year 1888 and is headquarter in Illinois, U.S. The company focuses on manufacturing devices in order to manage chronic pain and diabetes among others. The company operates its business via several business segments including established pharmaceutical products, nutritionals, diagnostics, medical devices, and others in which medical devices is the market focused segment.

The company also provides products via various product categories such as cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition, and medicines in which cardiovascular, diabetes care, neuromodulation is the market focused category.

For instance,

  • In July 2021, Abbott announced the launch of insert able cardiac monitor, Jot Dx in the U.S. The device helps clinicians to view abnormal heart rhythm and allows for remote detection and improved diagnosis accuracy of cardiac arrhythmia. This will help the company to further acquire the market in coming years.

The company has presence across Americas, Europe, and Asia-Pacific. It also has various subsidiaries including Abbott Cardiovascular Systems Inc. (U.S.), Abbott Nutrition Manufacturing Inc. (U.S.), Abbott Laboratories Pacific Ltd. (U.S.), Abbott Resources Inc. (U.S.) and PDD II, LLC (U.S.) among others

Boston Scientific Corporation

 Boston Scientific Corporation was founded in the year 1979 and is headquartered in Massachusetts, the U.S. The company is focusing on development, manufacture. and marketing of medical devices that are used in interventional medical specialties. The company operates its business via several business segments including Medical Surgical (MedSurg), rhythm, and neuro and cardiovascular in which rhythm and neuro is the market focused segment.

The company also provides products via various product category such as electrophysiology, female pelvic medicine, gastroenterology, gastrointestinal surgery, interventional cardiology, interventional radiology, neurological surgery, orthopedic surgery, pain medicine, pulmonology, urology, and vascular surgery in which interventional cardiology, neurological surgery are market focused categories.

For instance,

  • In January 2021, Boston Scientific announced that it has entered into an agreement to acquire Preventice Solutions, Inc. The acquisition will help the company to expand its cardiac portfolio.

The company has presence across Middle East and Africa, Americas, Europe, Asia-Pacific. It also has various subsidiaries including Guidant (U.S.), Vertiflex (U.S.), American Medical Systems, Inc. (U.S.), Augmenix Inc. (U.S.), Symetis SA (Switzerland) among others.